Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Elanís NanoCrystal Technology has been given EC approval: The European Commission has just approved the first injectable product using Elan Drug Technologies' NanoCrystal technology

Abstract:
The European Commission has just approved the first injectable product using Elan Drug Technologies' NanoCrystal technology. The approval of XEPLION , Janssen-Cilag International's long-acting injectable treatment for patients with schizophrenia uses Elan's technology.

Elanís NanoCrystal Technology has been given EC approval: The European Commission has just approved the first injectable product using Elan Drug Technologies' NanoCrystal technology

UK | Posted on March 12th, 2011

The approval of this technology represents an important step for NanoCrystal technology. Nanobiotechnology products are already available on the market place with the total market worth an estimated US$19.3 billion in 2010. By 2015, the forecast market size for nanbiotechnology is expected to total US$29.7 billion by 2015.

Medical applications, including drug delivery and microbicides represent one of the major nanobiotechnology sectors with sales totalling US$19.1 billion in 2010. The application of the nanotechnology in R&D is also an important growth area with DNA sequencing applying the technology recently.

The unique properties that nanomaterials provide enable value-added performance in a range of life science applications, from encapsulating and releasing drugs to biologic imaging. At the same time, the drug industry is searching for ways to extend drugs coming off patent as well as to improve drug pharmacokinetics. The diagnostics industry is seeking ways to better image molecular events to meet demand for new medicines. Nanobiotechnology, representing a diverse range of applications and materials, is the result of these converging forces.

Nanotechnology is already providing significant revenues in drug delivery applications in addition to diagnostics, microbicides, and R&D tools. The application of nanotechnology is being applied to drug formats including polymer, liposomal and nanocrystal drugs. Diagnostic and microbicide formats include nanoparticles, quantum dots, and dendrimers. Nanopore formats are emerging in third-generation DNA sequencing applications.

Author: Mike King, Analyst

####

About www.companiesandmarkets.com
Companiesandmarkets.com is home to one of the world's largest databases of market research reports and company profiles from leading global publishers and industry analysts. Multinational brands across major industries rely daily on companiesandmarkets.com for strategic market research and incisive company profiles. Clients have access to over 500,000 regularly updated market research reports, company profiles, SWOT analysis reports and company financials. This leading-edge business intelligence can be easily browsed by industry sector, or by searching our database by keyword, geography or report type.

For more information, please click here

Contacts:
Vertical Edge Limited
(www.companiesandmarkets.com)
35 Kingsland Road
Shoreditch
London
E2 8AA
United Kingdom

+44 203 086 8600

Copyright © www.companiesandmarkets.com

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

Infrared instrumentation leader secures exclusive use of Vantablack coating December 5th, 2016

Construction of practical quantum computers radically simplified: Scientists invent ground-breaking new method that puts quantum computers within reach December 5th, 2016

Nanomedicine

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the ďact.in.sarcĒ Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

Announcements

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

Infrared instrumentation leader secures exclusive use of Vantablack coating December 5th, 2016

Construction of practical quantum computers radically simplified: Scientists invent ground-breaking new method that puts quantum computers within reach December 5th, 2016

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

Construction of practical quantum computers radically simplified: Scientists invent ground-breaking new method that puts quantum computers within reach December 5th, 2016

Shape matters when light meets atom: Mapping the interaction of a single atom with a single photon may inform design of quantum devices December 4th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project